DALLAS, July 14, 2022 /PRNewswire/ — Trinity Hunt Partners, a growth-focused middle-market private equity firm, today announced the launch of Parallel ENT & Allergy Partners (“Parallel”), a management services organization focused on physicians for ear, nose and throat (“ENT”) and allergy practices. Parallel and its partners share a commitment to the highest quality patient care, sustainable growth and a culture of respect.

In March 2022, Parallel entered into a strategic partnership with ENT & Allergy of Delaware (“ENTAD”). Founded in 2010, ENTAD is a leading provider of ENT and Allergy services with a preeminent team of 15 physicians, 12 audiologists and over 140 support staff. ENTAD will continue to operate under its brand. “At ENTAD, we are proud of our reputation for the highest quality clinical care and our culture of collaboration, trust and respect,” said Dr. Kieran Connolly, MD, founder of ENTAD. “In Parallel and Trinity Hunt, we have found like-minded partners with the right experience and track record to accelerate ENTAD’s growth while preserving our clinical independence and core values.”

Parallel will provide scalable support services to ENTAD and future partner practices to promote long-term growth and allow providers to focus on delivering the highest quality patient care. Glenn Noble, a seasoned healthcare services executive with extensive operational and strategic experience, has joined Parallel as CEO. “I am thrilled to be working in tandem with ENTAD and Trinity Hunt to grow Parallel into a culture-focused, best-in-class leader in the ENT and Allergy space. Parallel has a clear strategic vision dedicated to simplifying the complex healthcare environment and improve the experiences of our ENT and Allergy partners, patients and employees,” said Glenn Noble.

Backing Parallel is Trinity Hunt Partners, a leading private equity firm with deep experience in healthcare. “We look forward to supporting Parallel in its growth initiatives, including additional affiliations with like-minded practices, as it evolves to become a leading player in the ENT and allergy market,” said Jean OakesDirector of Trinity Hunt.

Baird served as exclusive financial advisor and Stevens & Lee served as legal advisor to ENTAD. McGuireWoods LLP served as legal counsel to Trinity Hunt. Terms were not disclosed.

About parallel

Parallel ENT & Allergy Partners is a physician-centric management support organization for ENT and Allergy practices. Parallel shares a commitment to the highest quality patient care, sustainable growth and a culture of respect. Working in parallel with its partner practices, the management services organization offers scalable support services to foster long-term growth while preserving the clinical autonomy of its physicians.

Parallel brings together the best people, processes and technologies, and the highest standards of care, to pave the way for long-term success for practices, physicians and patients.

For more information, please visit https://parallenta.com

About Trinity Hunt Partners

Trinity Hunt Partners is a growth-focused middle-market private equity firm with over $1.2 billion assets under management focused on partnering with business owners to build world-class businesses in business, healthcare and consumer services. Trinity Hunt has earned a reputation for providing the strategic, operational and financial expertise needed to take entrepreneurial service businesses to the next level. The company has been consistently named one of Inc. Magazine’s Top 50 Founder-Friendly Private Equity Firms. In 2022, Trinity Hunt ranked No. 13 out of 517 private equity firms in the inaugural HEC-Dow Jones ranking of top performing small-cap private equity firms.

For more information, please visit www.trinityhunt.com.

Press contacts:
Avery Meginnis
Oblique partners
[email protected]
704.942.1598

SOURCE Trinity Hunt Partners